Sanofi (SNY)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 140.70B |
| Enterprise value | 159.41B |
| Trailing P/E | 29.89 |
| Forward P/E | 11.38 |
| PEG ratio (5-yr expected) | 0.82 |
| Price/sales (ttm) | 2.66 |
| Price/book (mrq) | 1.73 |
| Enterprise value/revenue | 3.05 |
| Enterprise value/EBITDA | 13.40 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.42 |
| 52-week change 3 | 2.63% |
| S&P500 52-week change 3 | 32.65% |
| 52-week high 3 | 58.97 |
| 52-week low 3 | 42.63 |
| 50-day moving average 3 | 55.44 |
| 200-day moving average 3 | 50.45 |
Share statistics
| Avg vol (3-month) 3 | 1.86M |
| Avg vol (10-day) 3 | 1.62M |
| Shares outstanding 5 | 2.51B |
| Implied shares outstanding 6 | 2.55B |
| Float 8 | 1.1B |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 11.03% |
| Shares short (13 Sept 2024) 4 | 10.76M |
| Short ratio (13 Sept 2024) 4 | 6.64 |
| Short % of float (13 Sept 2024) 4 | 0.48% |
| Short % of shares outstanding (13 Sept 2024) 4 | 0.43% |
| Shares short (prior month 15 Aug 2024) 4 | 11.37M |
Dividends & splits
| Forward annual dividend rate 4 | 2.04 |
| Forward annual dividend yield 4 | 3.67% |
| Trailing annual dividend rate 3 | 3.76 |
| Trailing annual dividend yield 3 | 6.77% |
| 5-year average dividend yield 4 | 3.70 |
| Payout ratio 4 | 111.96% |
| Dividend date 3 | 06 Jun 2024 |
| Ex-dividend date 4 | 09 May 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in EUR.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 30 Jun 2024 |
Profitability
| Profit margin | 8.95% |
| Operating margin (ttm) | 14.31% |
Management effectiveness
| Return on assets (ttm) | 4.16% |
| Return on equity (ttm) | 5.82% |
Income statement
| Revenue (ttm) | 47.08B |
| Revenue per share (ttm) | 18.81 |
| Quarterly revenue growth (yoy) | 7.50% |
| Gross profit (ttm) | N/A |
| EBITDA | 11.75B |
| Net income avi to common (ttm) | 4.22B |
| Diluted EPS (ttm) | 1.86 |
| Quarterly earnings growth (yoy) | -22.40% |
Balance sheet
| Total cash (mrq) | 6.79B |
| Total cash per share (mrq) | 5.43 |
| Total debt (mrq) | 23.75B |
| Total debt/equity (mrq) | 32.54% |
| Current ratio (mrq) | 1.00 |
| Book value per share (mrq) | 58.10 |
Cash flow statement
| Operating cash flow (ttm) | 8.12B |
| Levered free cash flow (ttm) | 4.6B |
© 2024 Yahoo. All rights reserved.